The PARticulars of Parkinson’s Disease

Slides:



Advertisements
Similar presentations
Parkinsons Disease Management in Primary Care. Introduction Progressive condition 1:500 whole population 1:50 of elderly 1:10 Nursing Home Residents.
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Parkinson’s Finding the cure Presentation
Parkinson’s Disease (PD)
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Is it a neurodegenerative brain disorder that progresses slowly in most people.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Parkinson’s Disease Busra Berika Yucel
Parkinson’s Disease By Devin Cornford
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Chapter 30 Agents Used to Treat Parkinson’s Disease.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Treatment of Parkinson Disease David Tran, 2013 Mercer University PharmD Candidate.
Salvador Dali (Painter) Mao Zedong (Chinese Politician) Michael J Fox (Actor) Pope John Paul II Muhammad Ali (Boxer) Janet Reno (Former AG)
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
PARKINSON’S DISEASE By: AARUSHI JAIN AMRUTA KAMBLE ANNETT MARY JACOB AVANTI DEO M.Sc. PRIST (09-11)
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
Sarah Ehlers & Brendan Valentine Parkinson’s Disease.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Katelyn Chaimson and Sean Guyot
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Drugs in parkinsonism ilos
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Parkinson’s Disease Angela Duncan June Why I Chose This Subject Common neurodegenerative disorder / in Scotland Expected increase.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Drugs Used for Parkinson’s Disease Chapter 15 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
ANTI- PARKINSONISM Dr: Samah Gaafar Al-shaygi.  Neurodegenerative diseases.  Dopamenergic neurones in substantia nigra.  Environmental* genetic factors.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Management of Parkinson’s disease (in the acute medical ward) C. M. James MD FRCP FAcadMEd Consultant Physician Withybush Hospital, Pembrokeshire.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Team (Phoenix) Presents Parkinson’s Disease Prepared in partial satisfaction of the requirements for GPC 126, Physiological Psychology Spring Semester,
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Disabilities – Part One RECR 120. Parkinson’s Disease Non-motor symptoms such as loss of smell, constipation, and sleep disorders may appear years before.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
A Primer for Clinicians and Administrators
Drugs Used for Parkinson’s Disease
Parkinson’s Disease.
Living With and Managing Motor and Non-motor Symptoms
Understanding Parkinsons Disease
Parkinson’s Disease Jose S. Santiago M.D..
Falon Fiorillo & Breeanna Fournier
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
Drugs for Degenerative Diseases of the Nervous System
Neurodegenerative diseases
Course Business Writing Assignment 8 was due before class today.
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

The PARticulars of Parkinson’s Disease Presented by: Cheryl A. Siefert, MNM Executive Director

James Parkinson described “Shaking Palsy” in 1817

Parkinson’s Disease Progressive neurodegenerative disease Degeneration of dopamine neurons

Dopamine Ensures smooth muscle movement 70% is lost before first outward symptom appears

Facts - Who Knew? 2nd most common neurodegenerative disorder to Alzheimer’s Affects approximately 1.5 million Americans 17,000 live Colorado Onset between 40 and 70 years Most common within the 60’s 5-10% of patients are under the age of 40 Slightly higher incidence in men Non-discriminatory: Found in any race or ethnic group.

No Known Cause Exploring Aging Environmental toxins: Pesticides Rural living Well water Viral Infections

Reduced Life Expectancy Mean survival after onset ~ 20 years Longer if dementia isn’t present Longer with L-dopa use

Common Causes of Death Pulmonary infection Aspiration Urinary tract infection Pulmonary embolism Complications of falls and fractures

Often unilateral with subtle features Onset Often unilateral with subtle features Resting tremor Loss of arm swing Slowness of movement

Symptoms Tremor – trembling in hands, feet, and/or legs at rest Rigidity – stiffness Bradykinesia – slow movement Impaired balance – unsteadiness (not initial symptom)

Secondary Signs Cognitive disorders dementia depression psychosis Motor Disorders less frequent blinking swallowing problems speech impairment

More Secondary Signs Loss of sense of smell Constipation Urinary issues Lightheadedness Heat intolerance Skin changes Insomnia Daytime sleepiness Sleep apnea Depression/Anxiety

Early Treatment To adequately control the symptoms of Parkinson’s disease while minimizing the adverse effects of drug therapy for as long as possible

Treatment - Medications Levodopa/Carbidopa – replaces dopamine Dopamine agonists – stimulate dopamine receptors COMT & MAO-B inhibitors – inhibits enzyme that breaks down dopamine Anticholinergic agents

On/Off - Language of PD Abrupt and unpredictable changes in motor state “ON” = medications are working to < PD symptoms “OFF” = symptomatic benefits have been lost

Disabling and difficult to control Complication of Meds Dyskinesia: abnormal, involuntary writhing type movements, wiggly and twisty Increase over time Disabling and difficult to control Levodopa

Complimentary Therapies Speech Music Yoga Exercise Massage Accupuncture

Exercise Improves mood, energy level, and sleep Improves gait, grip strength, and motor coordination

Diet & Nutrition A well-balanced diet (can help prevent constipation) Meals rich in protein may reduce absorption of levodopa

“As we await the discoveries, we have the human spirit” Wisdom “As we await the discoveries, we have the human spirit”

PAR provides programs and services intended to enhance the quality of life for individuals with Parkinson's disease and their families: In-home visits from the Case Assessment Team No-cost loans of needed medical equipment Participation in support groups and weekly exercise classes Information & Referral Helpline Newsletter/E-news Educational Seminars Lending Library & Educational Literature www.ParkinsonRockies.org